tiprankstipranks
Trending News
More News >
Innocan Pharma Corporation (TSE:INNO)
:INNO
Advertisement

InnoCan Pharma (INNO) Revenue

Compare
19 Followers

InnoCan Pharma Revenue

InnoCan Pharma had a revenue of 7.01M in the quarter ending Jun 30, 2025, with -10.13%. This bring the company's revenue in the last twelve months to 28.83M, Increased -5.38%. In the fiscal year ending Dec 31, 2024, InnoCan Pharma had annual revenue of 29.44M with 115.55% growth.
Revenue (ttm)
28.83M
Revenue Growth
21.46%
P/S Ratio
2.97
Revenue/Employee
C$2,676,091
Employees
11
Market Cap
C$87.50M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
29.44M15.78M+215.55%
Dec 31, 2023
13.66M11.10M+533.69%
Dec 31, 2022
2.56M2.36M+1,305.62%
Dec 31, 2021
196.00K188.00K+2,450.31%
Dec 31, 2020
8.00K-800,000.00%
Dec 31, 2019
Dec 31, 2018
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis